AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $5.42
- 52-wk high
- $28.12
- High
- $5.70
- 52-wk low
- $1.92
- Low
- $5.40
- Prev close
- $5.46
- Mkt cap
- $21.6M
- Volume
- 14.5K
- Beta
- 1.73
- P/B
- 1.4x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -58.6%
What do analysts expect?
No analyst estimates.
Questions about PBM filings
Are insiders buying or selling Psyence Biomedical Ltd. Common Shares (PBM) stock?
Neither. Psyence Biomedical Ltd. Common Shares (PBM) insiders filed no open-market purchases or sales in the 90 days to Oct 5, 2026, according to SEC Form 4 filings.
Which members of Congress have traded PBM recently?
None. No member of Congress disclosed a PBM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PBM smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position.
How top traders are positioned
No tracked top-trader positions in PBM right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
The latest quarter is still settling.
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Sep 28, 2026 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 20, 2025 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2025 | Jun 25, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Jan 23, 2025 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2024 | Sep 30, 2024 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2023 | Sep 30, 2023 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2023 | Jun 30, 2023 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2023 | Mar 31, 2023 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $22M
Valuation
- P/B1.42
Quality
- Operating margin0.0%
- ROE-58.6%
- ROA-31.3%
Growth
- Beta1.73
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace